Gilead Sciences: Tatiana Williams Leads the Way With the Transinclusive Group

When Tatiana Williams was growing up as a young Trans woman in Florida, she faced many challenges and hardships - but she didn't find many resources available to her

"Like a lot of my friends, it was hard to have stable housing and I participated in sex work for survival," says Tatiana. "I had friends losing their lives to senseless murders or complications from HIV."

It was at a support group for sex workers that Tatiana began to think more expansively about what she and her friends needed to stay safe and healthy. To create change, she began speaking to those in positions of power, and in doing so was elected to the Transgender Health in Action group for the Florida Department of Health, which provides peer-on-peer workshops for the Trans community addressing issues such as health, safety and stigma..

Additionally, Tatiana's passion to help her community find a safe space and connections to resources led Tatiana to create Transinclusive Group, a Black-led Trans people's rights advocacy group in Florida. The organization offers everything from helping to change individuals' gender on state IDs, to HIV counseling and job training - all the things Tatiana herself was looking for decades earlier.

Gilead TRANScend grantee
But the needs of the community are constantly evolving, and Tatiana saw firsthand how housing instability can have an impact on health and wellbeing. This year, she implemented a plan to remedy that - and with the support of a Gilead TRANScend grant, the Transinclusive Group opened a peer-run seven-bed housing program called CHOICES. The program is designed to be transitional. Residents can stay six months or so in housing and receive preventative healthcare, financial advice, job training and one-on-one case management.

"In this space, we can connect through our shared life experiences," says Tatiana. "A lot of our community members are experiencing challenges in their life so their healthcare kind of goes on the back burner. Here, we're able to keep them engaged in care and up to date with their doctor visits. We're hoping in the six months they're with us, they'll be able to move on to the next phase in their life."

The program is off to a great start, but already the need is outweighing the supply. The housing program isn't equipped to handle people with severe mental health issues, for example, and it doesn't have the security capacity to assist those fleeing from violence.

"People are always reaching out, but we only can do what we can do," Tatiana says. "Our goal is to be able to use this model and utilize the data we gather to see if we can get additional support, and maybe a larger space." This model of peer-run housing programs for Trans individuals adds an invaluable resource to the region.

"You are in a space where you know people understand your story and situation and are not going to judge you," Tatiana says. But her bigger goal is not just moving people out of a crisis situation but building a stronger community for the future. "How do we get to resiliency? How do we improve our quality of life together?" she asks. The key, Tatiana is sure, lies in community.

"We're doing this together and you're not alone," says Tatiana. "We understand you, we see you and we're meeting you exactly where you are."

Originally published by Gilead Sciences https://stories.gilead.com/articles/tatiana-williams-leads-the-way-with-the-transinclusive-group

Gilead Sciences, Wednesday, December 21, 2022, Press release picture

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.gilead.com/
Email: info@3blmedia.com

SOURCE: Gilead Sciences



View source version on accesswire.com:
https://www.accesswire.com/732759/Gilead-Sciences-Tatiana-Williams-Leads-the-Way-With-the-Transinclusive-Group

News Provided by ACCESSWIRE via QuoteMedia

GILD
The Conversation (0)
Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

Appoints global biopharma leader Paul Carter as Non-Executive Director to support next phase of strategic growth

Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system ("CNS") disorders, is delighted to announce the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.Paul Carter is a highly... Keep Reading...
CHMP Adopts Positive Opinion Recommending Hepcludex®  for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus

CHMP Adopts Positive Opinion Recommending Hepcludex® for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus

-- If Granted by the European Commission, Hepcludex will Become the Only Approved Treatment for HDV in the EU -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive... Keep Reading...
Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts

Gilead Remains Steadfast in Support for Hepatitis C Elimination Efforts

The recent national conversation on hepatitis C (HCV) is an encouraging step towards viral hepatitis elimination in the U.S. With its long history of leadership in viral hepatitis, Gilead continues to support efforts that focus on HCV elimination. Gilead is proud that its medicines have treated... Keep Reading...
Gilead Sciences Announces First Quarter 2023 Financial Results

Gilead Sciences Announces First Quarter 2023 Financial Results

Product Sales Excluding Veklury Increased 15% Year-Over-Year to $5.7 billion Biktarvy Sales Increased 24% Year-Over-Year to $2.7 billion Oncology Sales Increased 59% Year-Over-Year to $670 million Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first... Keep Reading...
Gilead Sciences Releases Inaugural ESG Impact Report

Gilead Sciences Releases Inaugural ESG Impact Report

Gilead Sciences recently released its inaugural Environmental, Social and Governance (ESG) Impact Report. This is an evolution of our traditional Year in Review, and uses the ESG framework to highlight the successes and achievements of the prior yearThough the report itself is new, our... Keep Reading...

Latest Press Releases

Related News